| Literature DB >> 8917744 |
O Neudorfer1, N Giladi, D Elstein, A Abrahamov, T Turezkite, E Aghai, A Reches, B Bembi, A Zimran.
Abstract
Gaucher disease, the most prevalent glycolipid storage disorder, is classically subdivided into types according to the presence or absence of neurological involvement. Type I has hitherto been considered non-neuronopathic. We present six cases and a review of the literature of Parkinsonian symptoms in type I Gaucher disease patients. The hallmark of this atypical Parkinsonian syndrome is a relatively severe clinical course with early appearance of neurological signs in the 4th to 6th decade of life, aggressive progression of the signs and refractoriness to conventional anti-Parkinson therapy. We discuss the implications of these findings in the light of enzyme replacement therapy for Gaucher disease.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8917744 DOI: 10.1093/qjmed/89.9.691
Source DB: PubMed Journal: QJM ISSN: 1460-2393